Policy & Medicine - Legal, Regulatory, and Compliance Issues

The Supreme Court on Tuesday handed down an important decision regarding how patent claims are handled on appeal. The U.S. Court…

Last month, the Centers for Medicare and Medicaid Services (CMS) issued three FAQs and a page of website guidance to supplement…

Drug advertisements that the Food and Drug Administration (FDA) believes minimize a product’s risks have long been one…

A recent article by Harry Pellman, M.D. entitled The importance of bias in education dispels some of the myths about…

Each year the HHS Office of Inspector General (OIG) solicits recommendations for new or modified safe harbor provisions…

Unlike the first Open Payments program year, which took place over a 5 month period from August 2013 – December 2013, the second…

The Food and Drug Administration seems poised for a busy 2015. The Agency’s Center for Drug Evaluation and Research (CDER) just…

Japanese pharmaceutical company, Daiichi Sankyo Inc., with U.S. headquarters in New Jersey, has agreed to pay $39 million to…

The Accreditation Council for Continuing Medical Education (ACCME) Board of Directors today announced that it has chosen…

CBI's 2015 Pharmaceutical Compliance Congress (PCC) will take place on January 27-28, 2015 at the Ritz Carlton in…